JP2024534216A5 - - Google Patents

Info

Publication number
JP2024534216A5
JP2024534216A5 JP2024513920A JP2024513920A JP2024534216A5 JP 2024534216 A5 JP2024534216 A5 JP 2024534216A5 JP 2024513920 A JP2024513920 A JP 2024513920A JP 2024513920 A JP2024513920 A JP 2024513920A JP 2024534216 A5 JP2024534216 A5 JP 2024534216A5
Authority
JP
Japan
Application number
JP2024513920A
Other languages
Japanese (ja)
Other versions
JP2024534216A (ja
JPWO2023031856A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/058234 external-priority patent/WO2023031856A1/en
Publication of JP2024534216A publication Critical patent/JP2024534216A/ja
Publication of JPWO2023031856A5 publication Critical patent/JPWO2023031856A5/ja
Publication of JP2024534216A5 publication Critical patent/JP2024534216A5/ja
Pending legal-status Critical Current

Links

JP2024513920A 2021-09-02 2022-09-01 Rnaアフィニティー精製のための組成物および方法 Pending JP2024534216A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163240027P 2021-09-02 2021-09-02
US63/240,027 2021-09-02
EP22315159.8 2022-07-20
EP22315159 2022-07-20
PCT/IB2022/058234 WO2023031856A1 (en) 2021-09-02 2022-09-01 Compositions and methods for rna affinity purification

Publications (3)

Publication Number Publication Date
JP2024534216A JP2024534216A (ja) 2024-09-18
JPWO2023031856A5 JPWO2023031856A5 (https=) 2025-09-08
JP2024534216A5 true JP2024534216A5 (https=) 2025-09-08

Family

ID=83362521

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513920A Pending JP2024534216A (ja) 2021-09-02 2022-09-01 Rnaアフィニティー精製のための組成物および方法

Country Status (5)

Country Link
US (1) US20240327847A1 (https=)
EP (1) EP4396363A1 (https=)
JP (1) JP2024534216A (https=)
AU (1) AU2022336615A1 (https=)
WO (1) WO2023031856A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022099003A1 (en) 2020-11-06 2022-05-12 Sanofi Lipid nanoparticles for delivering mrna vaccines
EP4539858A1 (en) 2022-06-17 2025-04-23 Sanofi Pasteur Inc. Compositions and methods for circular rna affinity purification
WO2025035120A1 (en) * 2023-08-10 2025-02-13 Board Of Regents, The University Of Texas System Aptamer-based purification of circular rnas

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
WO2004046321A2 (en) 2002-11-15 2004-06-03 Trustees Of Boston University Cis/trans riboregulators
WO2005106035A2 (en) 2004-04-09 2005-11-10 Cornell Research Foundation, Inc. Modular design and construction of nucleic acid molecules, aptamer-derived nucleic acid constructs, rna scaffolds, their expression, and methods of use
ES2746803T3 (es) * 2013-05-15 2020-03-06 Robert Kruse Traducción intracelular de ARN circular
EP3589734A4 (en) * 2017-03-02 2020-12-23 Meiragtx UK II Limited REGULATION OF GENE EXPRESSION BY CLIVING BY RNASE P MODULATED BY APTAMER
FR3081169B1 (fr) * 2018-05-15 2020-06-19 Messenger Biopharma Substitution de la coiffe des arn messagers par deux sequences d'arn introduites a leur extremite 5'
ES2970169T3 (es) 2018-12-27 2024-05-27 Lifeedit Therapeutics Inc Polipéptidos útiles para edición génica y métodos de uso

Similar Documents

Publication Publication Date Title
JP2024534216A5 (https=)
BR102022025291A2 (https=)
CL2025003885A1 (es) Moldeo de productos de fibra hueca moldeada
BR102023014872A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BY13169U (https=)
BY13165U (https=)
CN307048344S (https=)
CN307048231S (https=)
CN307047748S (https=)
CN307047565S (https=)
CN307046999S (https=)
CN307044820S (https=)
CN307044334S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
CN307049484S (https=)